Targeting estrogen mediated CYP4F2/CYP4F11-20-HETE metabolic disorder decelerates tumorigenesis in ER+ breast cancer.
Yang J, Li Y, Han X, Li T, Li D, Liu Q, Yan L, Li F, Pei X, Feng Y, Lin Z, Fu Z, Wang C, Sun Q, Li C.
Yang J, et al. Among authors: feng y.
Biochem Biophys Rep. 2024 Apr 12;38:101706. doi: 10.1016/j.bbrep.2024.101706. eCollection 2024 Jul.
Biochem Biophys Rep. 2024.
PMID: 38646426
Free PMC article.